New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 18957483.
- Also identified by DOI 10.1136/ard.2008.096917.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To identify new IgG autoantibodies in sera from patients with rheumatoid arthritis (RA). We tested serum samples from 19 patients with RA with given human leukocyte antigen (HLA)-DR genotypes, from 7 patients with spondylarthropathy, 2 patients with lupus, 4 patients with systemic sclerosis and 10 healthy individuals on 8268 human protein arrays. We identified four antigens (peptidyl arginine deiminase 4 (PAD4), protein kinase Cbeta1 (PKCbeta1), phosphatylinositol 4 phosphate 5 kinase type II gamma (PIP4K2C) and v raf murine sarcoma viral oncogene homologue B1 catalytic domain (BRAF)) that were recognised almost uniquely by sera from patients with RA on protein arrays. Using purified proteins, we confirmed that PAD4 and BRAF are recognised almost uniquely by patients with RA. We identified PAD4 and BRAF as RA specific autoantigens.
Medical subject headings
- Arthritis, Rheumatoid
- Autoantibodies
- Autoantigens
- Immunoglobulin G
- Protein Array Analysis